Enzene Biosciences

Enzene Biosciences launches Ranibizumab to treat neovascular AMD

Read more

Enzene Biosciences inaugurates R&D Center with open lab setup in Pune

Read more

Enzene Biosciences launches Bevacizumab

Read more

Enzene Biosciences launches Cetuximab, biosimilar of cancer drug Erbitux

Read more

Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab

Read more

Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets

Read more